Inmaculada Puertas

1.2k total citations
30 papers, 429 citations indexed

About

Inmaculada Puertas is a scholar working on Neurology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Inmaculada Puertas has authored 30 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 10 papers in Rheumatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Inmaculada Puertas's work include Neurological disorders and treatments (11 papers), Multiple Sclerosis Research Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Inmaculada Puertas is often cited by papers focused on Neurological disorders and treatments (11 papers), Multiple Sclerosis Research Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Inmaculada Puertas collaborates with scholars based in Spain and United States. Inmaculada Puertas's co-authors include Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, María de Toledo, Tomás López‐Alburquerque, José A. G. Agúndez, Elena Garcı́a-Martı́n, Julián Benito‐León, Carmen Martínez, Lluisa Rubio and Beatriz Barcenilla and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Inmaculada Puertas

29 papers receiving 420 citations

Peers

Inmaculada Puertas
Inmaculada Puertas
Citations per year, relative to Inmaculada Puertas Inmaculada Puertas (= 1×) peers Lemuel Racacho

Countries citing papers authored by Inmaculada Puertas

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Puertas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Puertas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Puertas more than expected).

Fields of papers citing papers by Inmaculada Puertas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Puertas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Puertas. The network helps show where Inmaculada Puertas may publish in the future.

Co-authorship network of co-authors of Inmaculada Puertas

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Puertas. A scholar is included among the top collaborators of Inmaculada Puertas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Puertas. Inmaculada Puertas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laso-García, Fernando, Rafael Gallego, Beatriz Chamorro, et al.. (2025). Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis. Frontiers in Immunology. 16. 1694021–1694021.
2.
Fernández-Fournier, Mireya, Fernando Laso-García, Mari Carmen Gómez-de Frutos, et al.. (2023). Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers. Frontiers in Immunology. 14. 1224217–1224217. 5 indexed citations
3.
Fernández-Fournier, Mireya, Beatriz Chamorro, Fernando Laso-García, et al.. (2023). Antibody Content against Epstein–Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing–Remitting Multiple Sclerosis. International Journal of Molecular Sciences. 24(18). 14192–14192. 6 indexed citations
4.
Fernández-Fournier, Mireya, Fernando Laso-García, Mari Carmen Gómez-de Frutos, et al.. (2023). Brain and immune system-derived extracellular vesicles mediate regulation of complement system, extracellular matrix remodeling, brain repair and antigen tolerance in Multiple sclerosis. Brain Behavior and Immunity. 113. 44–55. 22 indexed citations
5.
Puertas, Inmaculada, et al.. (2020). Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. SHILAP Revista de lepidopterología. 36(6). 403–411. 7 indexed citations
6.
Fernández-Fournier, Mireya, A. Tallón-Barranco, Beatriz Chamorro, Patricia Martínez‐Sánchez, & Inmaculada Puertas. (2015). Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon. BMC Neurology. 15(1). 141–141. 7 indexed citations
7.
Garcı́a-Martı́n, Elena, Carmen Martínez, Hortensia Alonso‐Navarro, et al.. (2011). Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharmacogenetics and Genomics. 21(7). 436–439. 28 indexed citations
8.
Garcı́a-Martı́n, Elena, Carmen Martínez, Hortensia Alonso‐Navarro, et al.. (2010). Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. Journal of Neurology. 258(2). 203–211. 24 indexed citations
9.
Garcı́a-Martı́n, Elena, Carmen Martínez, Hortensia Alonso‐Navarro, et al.. (2009). Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor. Movement Disorders. 24(13). 1910–1915. 22 indexed citations
10.
Garcı́a-Martı́n, Elena, Cristina Martínez Conesa, Hortensia Alonso‐Navarro, et al.. (2009). Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor. European Journal of Neurology. 17(6). 879–881. 8 indexed citations
11.
Puertas, Inmaculada, et al.. (2008). Hemimasticatory Spasm Secondary to Biopercular Syndrome. European Neurology. 59(5). 276–279. 15 indexed citations
12.
Ledesma, María C., Elena Garcı́a-Martı́n, Hortensia Alonso‐Navarro, et al.. (2008). The Nonsynonymous Thr105Ile Polymorphism of the Histamine N-Methyltransferase is Associated to the Risk of Developing Essential Tremor. NeuroMolecular Medicine. 10(4). 356–361. 23 indexed citations
13.
Conesa, Cristina Martínez, Elena Garcı́a-Martı́n, Hortensia Alonso‐Navarro, et al.. (2008). Glutathione‐S‐transferase P1 polymorphism and risk for essential tremor. European Journal of Neurology. 15(3). 234–238. 13 indexed citations
14.
Jiménez‐Jiménez, Félix Javier, María de Toledo, Hortensia Alonso‐Navarro, et al.. (2007). Environmental Risk Factors for Essential Tremor. European Neurology. 58(2). 106–113. 44 indexed citations
15.
Martínez, Carmen, Elena Garcı́a-Martı́n, Hortensia Alonso‐Navarro, et al.. (2007). Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor. NeuroMolecular Medicine. 9(2). 195–204. 16 indexed citations
16.
Martı́nez, Carmen, Elena Garcı́a-Martı́n, Hortensia Alonso‐Navarro, et al.. (2007). Alcohol Dehydrogenase 2 Genotype and Allelic Variants Are Not Associated With the Risk for Essential Tremor. Clinical Neuropharmacology. 30(4). 196–200. 18 indexed citations
17.
Alonso‐Navarro, Hortensia, Carmen Martínez, Elena Garcı́a-Martı́n, et al.. (2006). <i>CYP2C19</i> Polymorphism and Risk for Essential Tremor. European Neurology. 56(2). 119–123. 28 indexed citations
18.
Jiménez‐Jiménez, Félix Javier, Ángel Hernánz, F. de Bustos, et al.. (2005). Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 111(2). 114–117. 35 indexed citations
19.
Puertas, Inmaculada, et al.. (2003). Progressive Cerebellar Syndrome as the First Manifestation of HIV Infection. European Neurology. 50(2). 120–121. 5 indexed citations
20.
Jiménez‐Jiménez, Félix Javier, María de Toledo, Inmaculada Puertas, et al.. (2002). La olanzapina mejora el corea en pacientes con enfermedad de Huntington. Revista de Neurología. 35(6). 524–524. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026